Cardinal Health Acquires Solaris Health, Expanding Urology Services and Strengthening Market Position

Cardinal Health Strengthens Urology Services with Solaris Health Acquisition

Cardinal Health continues to solidify its position in the healthcare sector with the recent acquisition of Solaris Health, a premier urology management services organization (MSO) in the United States. This strategic acquisition, announced on November 3, 2025, adds more than 750 healthcare providers and 250 practice locations across 14 states to Cardinal Health's existing capabilities. As a result, the company’s multi-specialty MSO platform, known as The Specialty Alliance, now encompasses approximately 3,000 providers across 32 states, significantly enhancing its scale and operational capabilities in the urology field.

The integration of Solaris Health into Cardinal Health’s network aligns with the company’s commitment to delivering customer-centric healthcare solutions. By expanding its reach and resources in urology management, Cardinal Health aims to improve the quality of care provided to patients, addressing a critical area of healthcare that requires specialized management and attention. This move not only enhances Cardinal Health's service offerings but also positions it as a more formidable player in the competitive healthcare landscape. The acquisition reflects a broader trend within the industry, where organizations seek to consolidate and expand their capabilities to meet growing patient needs.

In addition to the Solaris Health acquisition, Cardinal Health maintains a diverse portfolio that includes the distribution of pharmaceuticals, specialty products, and various medical and laboratory supplies. The company also operates nuclear pharmacies and provides home health services, emphasizing its focus on innovative solutions that enhance healthcare delivery. With these strategic initiatives, Cardinal Health is poised to drive continuous improvement in patient care, while further expanding its influence in the healthcare market.

In a related announcement, Cardinal Health’s Board of Directors has approved a quarterly dividend of $0.5107 per share, payable on January 15, 2026, to shareholders recorded by January 2, 2026. This reflects the company’s strong financial position and commitment to returning value to its shareholders amidst ongoing strategic expansions.

The acquisition of Solaris Health, coupled with the recent launch of the Kendall SCD SmartFlow™ Compression System, underscores Cardinal Health's dedication to innovative healthcare solutions. These initiatives demonstrate the company's proactive approach to enhancing patient care and solidifying its market presence. For further details about Cardinal Health's ongoing developments, stakeholders are encouraged to visit the company's official website or contact their media relations representatives.